000 01430 a2200445 4500
005 20250518050619.0
264 0 _c20200115
008 202001s 0 0 eng d
022 _a1477-0962
024 7 _a10.1177/0961203319861680
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, C
245 0 0 _aDifferences in clinico-pathological characteristics and outcomes between proteinase 3-ANCA positivity and myeloperoxidase-ANCA positivity in lupus nephritis.
_h[electronic resource]
260 _bLupus
_cAug 2019
300 _a1111-1119 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntibodies, Antineutrophil Cytoplasmic
_ximmunology
650 0 4 _aAntibodies, Antinuclear
_ximmunology
650 0 4 _aCohort Studies
650 0 4 _aCreatinine
_xblood
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aLupus Nephritis
_ximmunology
650 0 4 _aMale
650 0 4 _aMyeloblastin
_ximmunology
650 0 4 _aPeroxidase
_ximmunology
650 0 4 _aRetrospective Studies
650 0 4 _aYoung Adult
700 1 _aWang, J-J
700 1 _aZhou, M-L
700 1 _aLiang, D-D
700 1 _aYang, J
700 1 _aZhu, H-X
700 1 _aHu, W-X
700 1 _aZhang, H-T
773 0 _tLupus
_gvol. 28
_gno. 9
_gp. 1111-1119
856 4 0 _uhttps://doi.org/10.1177/0961203319861680
_zAvailable from publisher's website
999 _c29887644
_d29887644